1. Home
  2. Products
  3. Customized FluoroAb™
  4. IL17RA
  5. Anti-IL17RA MAb (Clone 3)-iFluor® 532 Succinimidyl Ester

Anti-IL17RA MAb (Clone 3)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13625)

This product is comprised of an Human Anti-IL17RA IgG2-kappa (Clone 3) labeled with iFluor® 532 Succinimidyl Ester. iFluor® 532 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.

  • TARGET
  • ANTIBODY
  • DYE
  • Name
  • IL17RA
  • Overview
  • Human Anti-IL17RA IgG2-kappa (Clone 3)
  • Species Reactivity
  • Human
  • Name
  • iFluor® 532 Succinimidyl Ester
  • Color
  • Green
  • Excitation⁄Emission (nm)
  • 537/560
  • Detection method
  • Fluorescent

For Research Use Only. NOT FOR CLINICAL USE.

Published Data

+ Submit Publications

Submit a review or a question

Scientific Resources

Customer Reviews and FAQs

There are currently no Customer reviews or questions for WJY0-LS13625. Click the button above to contact us or submit your feedback about this product.

Quick Links

Other Products

Same Target
CAT# Product Name Linker Payload
ADC-W-1325 Anti-IL17RA (Ixekizumab)-MC-Vc-PAB-MMAE ADC MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) MMAE
ADC-W-1323 Anti-IL17RA (Ixekizumab)-SPDB-DM4 ADC SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine)
ADC-W-1320 Anti-IL17RA (Brodalumab)-MC-Vc-PAB-SN38 ADC MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) SN-38 (7-ethyl-10-hydroxycamptothecin)
ADC-W-1327 Anti-IL17RA (Ixekizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC MC-Vc-PAB-DMEA-(PEG2) duocarmycin SA
ADC-W-1317 Anti-IL17RA (Brodalumab)-SPDB-DM4 ADC SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine)

Online Inquiry

Name:
*Phone:
*E-mail Address:
*Products or Services Interested:
Company/Institution
Project Description:

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.